SCHEMBL2961675

SCHEMBL2961675

CCC(Br)[C]1C=Cc2ccccc21

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 4/20 0.39
▸ CYP1A2 P05177 3/20 0.39
▸ CYP2D6 P10635 3/20 0.39
▸ HTR1A P08908 3/20 0.39
▸ DRD2 P14416 3/20 0.39
▸ HTR2A P28223 3/20 0.39
▸ SLC6A4 P31645 3/20 0.39
▸ HRH1 P35367 3/20 0.39
▸ ALOX15 P16050 2/20 0.39
▸ TP53 P04637 2/20 0.39
▸ CHRM2 P08172 2/20 0.39
▸ CHRM1 P11229 2/20 0.39
▸ TSHR P16473 2/20 0.39
▸ ADRA2C P18825 2/20 0.39
▸ CHRM3 P20309 2/20 0.39
▸ SLC6A2 P23975 2/20 0.39
▸ HTR2C P28335 2/20 0.39
▸ ADRA1A P35348 2/20 0.39
▸ DRD3 P35462 2/20 0.39
▸ HTR2B P41595 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2969592 0.85 SETD7 (0.35) LMNACYP1A2CYP2D6HTR1ADRD2
SCHEMBL217320 0.78 TSHR (0.39) LMNACYP1A2CYP2D6HTR1ADRD2
SCHEMBL2958225 0.78 LMNA (0.39) LMNACYP1A2CYP2D6HTR1ADRD2
SCHEMBL2963367 0.77 SETD7 (0.37) LMNACYP1A2CYP2D6HTR1ADRD2
SCHEMBL218143 0.73 MEN1 (0.41) LMNACYP1A2CYP2D6HTR1ADRD2
SCHEMBL217390 0.72 SETD7 (0.36) LMNACYP1A2CYP2D6HTR1ADRD2
SCHEMBL27932919 0.71 LMNA (0.36) LMNACYP1A2CYP2D6HTR1ADRD2
SCHEMBL28806997 0.71 LMNA (0.36) LMNACYP1A2CYP2D6HTR1ADRD2
SCHEMBL2959610 0.70 SETD7 (0.35) LMNACYP1A2CYP2D6HTR1ADRD2
SCHEMBL2965393 0.69 LMNA (0.39) LMNACYP1A2CYP2D6HTR1ADRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7763562-B2 Heteroatom bridged metallocene compounds for olefin polymerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2010-07-27 — — US disclosed
US-20070135597-A1 Heteroatom bridged metallocene compounds for olefin polymerization EXXONMOBIL CHEMICAL PATENTS INC. 2007-06-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070135597-A1 Heteroatom bridged metallocene compounds for olefin polymerization AP2M1, AP1M1, PYM1 LMNA 2058/4885CYP1A2 2409/4885CYP2D6 2519/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback